Adults with differentiated thyroid cancer have a high 10-year disease-specific survival, even with radioactive iodine not ...

Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment. According to new ...

The rates of recurrence-free and disease-specific survival were comparable between patients with differentiated thyroid cancer with immunocompromised status and matched patients with immunocompetent ...

A Sarasota Memorial specialist helped create new guidelines for treating differentiated thyroid cancer. The "2025 American Thyroid Association Management Guidelines" are the first update since 2015.

Thyroid cancer is often a highly treatable disease. Most cases are detected in early stages and have excellent outcomes. There are several different types of thyroid cancer, and recent changes in ...

There is no universally accepted definition for recurrence of differentiated thyroid cancer (DTC) across treatment categories such as total thyroidectomy with or without radioactive iodine ablation ...

Please provide your email address to receive an email when new articles are posted on . Of 155 young patients diagnosed with differentiated thyroid cancer, 52.3% had excellent response to treatment.

Postoperative radioiodine (RAI) versus no radiodine therapy for patients with low-risk differentiated thyroid cancer: A systematic review and meta-analysis. Survival outcomes in radioactive ...

While any cancer diagnosis is frightening, thyroid cancer has a remarkably high cure rate when caught early. Here, a top surgeon shares everything you need to know about thyroid cancer ...